PL2595960T3 - Sól i solwaty pochodnej tetrahydroizochinoliny - Google Patents

Sól i solwaty pochodnej tetrahydroizochinoliny

Info

Publication number
PL2595960T3
PL2595960T3 PL11740973.0T PL11740973T PL2595960T3 PL 2595960 T3 PL2595960 T3 PL 2595960T3 PL 11740973 T PL11740973 T PL 11740973T PL 2595960 T3 PL2595960 T3 PL 2595960T3
Authority
PL
Poland
Prior art keywords
solvates
salt
tetrahydroisoquinoline derivative
tetrahydroisoquinoline
derivative
Prior art date
Application number
PL11740973.0T
Other languages
English (en)
Inventor
Thomas David Mccarthy
Peter Michael Kelly
Craig James Stewart Boyle
Alexander Redvers Eberlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2595960T3 publication Critical patent/PL2595960T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL11740973.0T 2010-07-21 2011-07-21 Sól i solwaty pochodnej tetrahydroizochinoliny PL2595960T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36636710P 2010-07-21 2010-07-21

Publications (1)

Publication Number Publication Date
PL2595960T3 true PL2595960T3 (pl) 2016-09-30

Family

ID=44386640

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11740973.0T PL2595960T3 (pl) 2010-07-21 2011-07-21 Sól i solwaty pochodnej tetrahydroizochinoliny

Country Status (20)

Country Link
US (3) US8614227B2 (pl)
EP (2) EP2595960B1 (pl)
JP (3) JP5948326B2 (pl)
CN (2) CN103003244B (pl)
AU (3) AU2011281381B2 (pl)
CA (1) CA2803699C (pl)
DK (1) DK2595960T3 (pl)
ES (1) ES2570135T3 (pl)
HK (1) HK1224290A1 (pl)
HR (1) HRP20160540T1 (pl)
HU (1) HUE028620T2 (pl)
ME (1) ME02407B (pl)
NZ (2) NZ605444A (pl)
PL (1) PL2595960T3 (pl)
PT (1) PT2595960E (pl)
RS (1) RS54789B1 (pl)
SI (1) SI2595960T1 (pl)
SM (1) SMT201600171B (pl)
WO (1) WO2012010843A1 (pl)
ZA (1) ZA201300169B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ605444A (en) * 2010-07-21 2015-06-26 Spinifex Pharm Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative
US9320530B2 (en) * 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
NZ630908A (en) * 2013-07-08 2017-08-25 Novartis Ag Heterocyclic compounds and methods of their use
CN107001337B (zh) 2015-01-13 2021-05-04 诺华股份有限公司 作为血管紧张素ii型拮抗剂的吡咯烷衍生物
ES2898635T3 (es) 2015-03-12 2022-03-08 Novartis Ag Compuestos heterocíclicos y métodos para su uso
CN106478502B (zh) * 2015-08-29 2021-04-27 上海翰森生物医药科技有限公司 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用
EP3475261A1 (en) 2016-06-27 2019-05-01 ratiopharm GmbH Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid
WO2018172950A1 (en) * 2017-03-23 2018-09-27 Novartis Ag Anhydrous crystalline forms of sodium (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylate
KR102132761B1 (ko) * 2017-06-09 2020-07-17 산동 단홍 파머수티컬 컴퍼니., 리미티드. At2r 수용체 길항제로서의 카르복시산 유도체
WO2020012266A1 (en) 2018-07-12 2020-01-16 Novartis Ag Biocatalytic synthesis of olodanrigan (ema401) from 3-(2-(benzyloxy)-3-methoxyphenyl)propenoic acid with phenylalanine ammonia lyase
EP3820833A4 (en) 2018-07-12 2022-08-03 Codexis, Inc. MODIFIED AMMONIA-LYASE PHENYLALANINE POLYPEPTIDES
CN111620816B (zh) * 2020-05-27 2023-06-02 上海赛默罗生物科技有限公司 螺桨烷类衍生物、其制备方法、药物组合物和用途
GB202100352D0 (en) * 2021-01-12 2021-02-24 Balticgruppen Bio Ab New methods
CN115901740A (zh) * 2022-11-18 2023-04-04 南京工业大学 基于Pictet-Spengler反应的多巴胺检测试剂及应用、多巴胺的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246943A (en) 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5236934A (en) 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
AU747110B2 (en) * 1998-02-25 2002-05-09 Merck & Co., Inc. Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist
NZ555334A (en) * 2004-12-24 2010-05-28 Spinifex Pharm Pty Ltd Method of treatment or prophylaxis of a neuropathic condition using AT2 receptor antagonist
JP5230595B2 (ja) 2006-03-20 2013-07-10 スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド 炎症性疼痛の治療または予防の方法
ES2560327T3 (es) * 2010-01-19 2016-02-18 Novartis Ag Métodos y composiciones para una velocidad de conducción nerviosa mejorada
NZ605444A (en) * 2010-07-21 2015-06-26 Spinifex Pharm Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative

Also Published As

Publication number Publication date
AU2011281381B2 (en) 2015-07-16
AU2015238774A1 (en) 2015-10-29
CN105777636A (zh) 2016-07-20
US8927575B2 (en) 2015-01-06
HRP20160540T1 (hr) 2016-06-17
ZA201300169B (en) 2016-03-30
JP2017214415A (ja) 2017-12-07
JP5948326B2 (ja) 2016-07-06
NZ708529A (en) 2016-11-25
ME02407B (me) 2016-09-20
CA2803699A1 (en) 2012-01-26
NZ605444A (en) 2015-06-26
DK2595960T3 (en) 2016-05-09
HUE028620T2 (en) 2016-12-28
RS54789B1 (sr) 2016-10-31
EP2595960B1 (en) 2016-02-24
JP2016164178A (ja) 2016-09-08
CN103003244B (zh) 2016-04-20
AU2017203236A1 (en) 2017-06-08
SMT201600171B (it) 2016-07-01
JP2013531057A (ja) 2013-08-01
US20150105422A1 (en) 2015-04-16
US20120022101A1 (en) 2012-01-26
EP2595960A1 (en) 2013-05-29
WO2012010843A1 (en) 2012-01-26
ES2570135T3 (es) 2016-05-17
US20140080865A1 (en) 2014-03-20
CA2803699C (en) 2016-05-31
EP3081557A1 (en) 2016-10-19
HK1224290A1 (en) 2017-08-18
US9162985B2 (en) 2015-10-20
AU2011281381A1 (en) 2013-01-10
SI2595960T1 (sl) 2016-06-30
PT2595960E (pt) 2016-06-02
US8614227B2 (en) 2013-12-24
CN103003244A (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
ZA201300169B (en) Salt and solvates of a tetrahydroisoquinoline derivative
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
ZA201209205B (en) Pyridone and aza-pyridone compounds and methods of use
HUE038574T2 (hu) Adagkapszula és adagkapszula alkalmazása
IL220939A0 (en) Compounds and methods
EP2523664A4 (en) COMPOUNDS AND METHODS
SI2623497T1 (sl) Megluminska sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
ZA201301120B (en) Heterocyclic compound and use thereof
SI2623498T1 (sl) Natrijeva sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
IL220812A0 (en) Compounds and methods
AP3917A (en) Subsea anchor
EP2640190A4 (en) MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
EP2523560A4 (en) CONNECTIONS AND METHODS
GB201018124D0 (en) Polymorphs and salts
GB201006680D0 (en) Alarm
ZA201209666B (en) Salts and polymorhs of dexrabeprazole
PL2552910T3 (pl) Nowy polimorf
ZA201400248B (en) Synthesis of cleistainthin a and derivatives thereof
AP2012006419A0 (en) Aminoquinoline derivatives
GB201004450D0 (en) Compounds and methods relating thereto
IL225708A0 (en) Methods for the synthesis of scylitol and related compounds
TWM402081U (en) Bathtub
HK1180343A (en) Salt and solvates of a tetrahydroisoquinoline derivative
HU1000688D0 (en) Use of trifluoro-phal